WO2004071267A3 - Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample - Google Patents

Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample Download PDF

Info

Publication number
WO2004071267A3
WO2004071267A3 PCT/EP2004/001152 EP2004001152W WO2004071267A3 WO 2004071267 A3 WO2004071267 A3 WO 2004071267A3 EP 2004001152 W EP2004001152 W EP 2004001152W WO 2004071267 A3 WO2004071267 A3 WO 2004071267A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
colorectal cancer
nicotinamide
methyltransferase
detection
Prior art date
Application number
PCT/EP2004/001152
Other languages
French (fr)
Other versions
WO2004071267A2 (en
Inventor
Peter Berndt
Marie-Luise Hagmann
Hanno Langen
Stefan Palme
Markus Roessler
Wolfgang Rollinger
Michael Tacke
Werner Zolg
Original Assignee
Roche Diagnostics Gmbh
Hoffmann La Roche
Peter Berndt
Marie-Luise Hagmann
Hanno Langen
Stefan Palme
Markus Roessler
Wolfgang Rollinger
Michael Tacke
Werner Zolg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh, Hoffmann La Roche, Peter Berndt, Marie-Luise Hagmann, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Michael Tacke, Werner Zolg filed Critical Roche Diagnostics Gmbh
Publication of WO2004071267A2 publication Critical patent/WO2004071267A2/en
Publication of WO2004071267A3 publication Critical patent/WO2004071267A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon

Abstract

The present invention relates to the diagnosis of colorectal cancer. It discloses the use of nicotinamide N­methyltransferase NNMT in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual by measuring NNMT in said sample. Measurement of NNMT can, e.g., be used in the early detection or diagnosis of colorectal cancer.
PCT/EP2004/001152 2003-02-11 2004-02-09 Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample WO2004071267A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03002651.2 2003-02-11
EP03002651 2003-02-11

Publications (2)

Publication Number Publication Date
WO2004071267A2 WO2004071267A2 (en) 2004-08-26
WO2004071267A3 true WO2004071267A3 (en) 2004-10-21

Family

ID=32864921

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/001152 WO2004071267A2 (en) 2003-02-11 2004-02-09 Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample

Country Status (1)

Country Link
WO (1) WO2004071267A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006044680A1 (en) * 2004-10-14 2006-04-27 The Cleveland Clinic Foundation Methods of detecting colorectal cancer
WO2007071366A1 (en) * 2005-12-21 2007-06-28 Roche Diagnostics Gmbh Method of assessing colorectal cancer by measuring hemoglobin and m2-pk in a stool sample
US10087449B2 (en) 2014-04-07 2018-10-02 Shionogi & Co., Ltd. Pharmaceutical composition for treating chronic kidney disease
CN106248946A (en) * 2016-08-19 2016-12-21 浙江大学 A kind of enzyme-linked immunologic detecting kit and application thereof
EP3431609B1 (en) 2017-07-17 2020-02-12 Masarykova Univerzita Method of diagnosis of colorectal cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002070742A1 (en) * 2001-03-01 2002-09-12 Epigenomics Ag Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002070742A1 (en) * 2001-03-01 2002-09-12 Epigenomics Ag Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AHLQUIST D A: "FECAL OCCULT BLOOD TESTING FOR COLORECTAL CANCER CAN WE AFFORD TO DO THIS?", GASTROENTEROLOGY CLINICS OF NORTH AMERICA, XX, XX, vol. 26, no. 1, March 1997 (1997-03-01), pages 41 - 55, XP008021412 *
AOYAMA K ET AL: "Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease.", NEUROSCIENCE LETTERS. 26 JAN 2001, vol. 298, no. 1, 26 January 2001 (2001-01-26), pages 78 - 80, XP002237184, ISSN: 0304-3940 *
OKAMURA A ET AL: "INCREASED HEPATIC NICOTINAMIDE N-METHYLTRANSFERASE ACTIVITY AS A MARKER OF CANCER CACHEXIA IN MICE BEARING COLON 26 ADENOCARCINOMA", JAPANESE JOURNAL OF CANCER RESEARCH, JAPANESE CANCER ASSOCIATION, TOKYO, JP, vol. 89, no. 6, June 1998 (1998-06-01), pages 649 - 656, XP009008878, ISSN: 0910-5050 *
PARSONS RICHARD B ET AL: "Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain", JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, vol. 61, no. 2, February 2002 (2002-02-01), pages 111 - 124, XP009033873, ISSN: 0022-3069 *
SIEG ANDREAS ET AL: "Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol. 14, no. 6, December 1999 (1999-12-01), pages 267 - 271, XP002288706, ISSN: 0179-1958 *

Also Published As

Publication number Publication date
WO2004071267A2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
KR100711046B1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
EP2021794B8 (en) Use of protein s100a 12 as a marker for colorectal cancer
WO2008039946A3 (en) Integrated meter for analyzing biological samples
SI1776587T1 (en) Use of c3a and derivatives thereof as biomarker for colorectal adenoma and/or carcinoma ; diagnosis methods and assays using the same
TW200636245A (en) Colorimetric sensors constructed of diacetylene materials
WO2007064567A3 (en) Apparatus and method for measuring real-time corrosion
WO2003040728A3 (en) Method and apparatus for the determination of glucose
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
WO2005104659A3 (en) Method and system for approximating the spectrum of a plurality of color samples
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2004057341A3 (en) Cvd assay
WO2004094675A3 (en) Compositions and methods for determining the presence of sars coronavirus in a sample
WO2007061940A3 (en) Method for detecting an inflammatory disease or cancer
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2007092552A3 (en) Device and methods for detecting and quantifying one or more target agents
EP1865067A4 (en) Method for study, determination or evaluation
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
WO2006133385A3 (en) Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample
WO2009007649A3 (en) Device and method for identifying and determining blood groups
WO2005074522A3 (en) Detection of ruminant dna via pcr
WO2004071267A3 (en) Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
WO2007121209A3 (en) Methods and devices for non-invasive analyte measurement

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application